chrisvoncsefalvay/vaers-outcomes huggingface dataset:
painful cyst filled with fluid under armpit; painful cyst filled with fluid under armpit; This spontaneous case was reported by a consumer and describes the occurrence of CYST (painful cyst filled with fluid under armpit) and PAIN (painful cyst filled with fluid under armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CYST (painful cyst filled with fluid under armpit) and PAIN (painful cyst filled with fluid under armpit). At the time of the report, CYST (painful cyst filled with fluid under armpit) and PAIN (painful cyst filled with fluid under armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not reported.  Relevant concomitant medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Non-Significant Follow Up Appended- Ae contact info updated
Information has been received from a Physician assistant concerning a 42 year old female patient with cardiovascular disease and smoker who on 17-MAR-2011, was vaccinated with PNEUMOVAX 23 (route, expiration date and lot number not reported). Concomitant therapy including metformin (manufacturer unknown), lisinopril (manufacturer unknown), lovastatin (manufacturer unknown), vitamins (unspecified), Lactobacillus acidophilus, ranitidine and PREVACID. At the same time, the patient was given diphtheria toxoid (+) paratyphoid A vaccine (+) paratyphoid B vaccine (+) tetanus toxoid (+) typhoid vaccine inactivated (manufacturer unknown) in the opposite arm. On an unknown date, the patient experienced a red swollen arm, pain across the chest and shortness of breath. The patient received as treatment for the event BENADRYL. The patient sought unspecified medical attention. At the time of the report the patient was recovered. The patient sought unspecified medical attention. Additional information has been requested.
Got booster shot, got shingles the next day; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient had when he was about ten.).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   The reporter considered the shingles to be possibly related to Shingles vaccine.     Additional Information: GSK Receipt Date: 01-FEB-2023 Reporter's Comment: This case was reported by the patient via interactive digital media.  The patient got booster shot and started getting shingles the next day. The patient also had shingles when he was about ten. Additional supportive information: Follow-up would not possible as no contact details were available.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 03-APR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml Prefilled Syringe (PFS) (lot # K020795, expiration date 19-MAR-2016, dose and route were unspecified). This specified lot number vaccine was exposed temperature excursion twice. The total cumulative excursion time of the first time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 64 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Client states a little pain and swelling on Tuesday, September 26 with increasing pain and swelling on Sunday October 1, 2006.  On Thursday, October 5, when seen by RN, Left deltoid slightly reddened with not edema present with little discomfort voiced.
No adverse effects; Improperly stored (-8.89 Celsius degree for 1 hour) VARIVAX was administered to the patient; Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were not provided.   On 05-APR-2019, the patient was administered improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number R026547, expiration date 17-SEP-2020; strength, dose and frequency were not reported) was subcutaneously for prophylaxis with properly stored sterile diluent (No lot information was provided). The administered dose experienced a temperature excursion of -8.89 degree Celsius for 1 hour which were detected by a data logger. No previous excursions were reported. No adverse effects was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA005132: US-009507513-1904USA005131: US-009507513-1904USA005130: US-009507513-1904USA004258: US-009507513-1904USA005129: US-009507513-1904USA005630: US-009507513-1904USA005629: US-009507513-1904USA005628: US-009507513-1904USA005133: US-009507513-1904USA005627:
Tingling in lungs, mouth for 15 minutes Tingling and numbness in jaws for over a month Tinnitus for 2 weeks Migraine/headaches: a week
24-48hr p/vax fatigue, fever 102, lt arm red, sore, achy, chest lightness, lt shoulder soreness rash (fine papular) on neck & trunk;area of erythema lt arm 8x5cm;
Within 5 min of receiving the vaccine injection, pt complained of being dizzy. EMT's on site took BP and found it to be significantly elevated. EMT's called the local clinic and spoke to the PA on duty. They advised the EMT's to transport the pt to the hospital for treatment.
Patient received Moderna bi-valent, along with FluAD on 10/10/22 at roughly 5pm. Patient called at 10am Wednesday 10/12/22 to discuss possible reaction. Patient stated the area was red, itchy, and swollen to the size of a "doughnut". Patient was advised to follow-up with PCP, however declined recommendation. Patient stated the area was "less hard" than it was yesterday and that she would continue to monitor over next day.
Patient was administered third dose of Moderna on 10/13/21 but the vial in which the dose was drawn from expired on 10/12/21
This spontaneous literature report (initial receipt 28-Nov-2011) concerns children aged 2-17 years who received trivalent inactivated vaccine. The study included a total of 4245 and 10693 children who received 1 dose or greater of LAIV in year 1 of 6 TIV - controlled and 14 placebo-controlled studies, respectively. All reported adverse events considered to be wheezing, asthma, bronchial obstruction or bronchospasm (including bronchiolitis) were grouped into wheezing events of special interest. Lower respiratory or respiratory difficulty. Reactogenicity events included runny/stuffy nose, sore throat, cough, vomiting, headache, muscle ache, chills, decreased activity, irritability, abdominal pain, decreased appetite, and fever. In the 0-10 days post vaccination, it was reported that in year 1 of vaccination with TIV (dose 1), 755 patients reported >=1 events (1103 events in total); events of interest included 110 incidences of lower respiratory illness and 68 incidences of wheezing illness; and in year 1 (dose 2), 363 patients reported > 1 events (519 events in total); events of interest included 60 incidences of lower respiratory illness and 30 incidences of wheezing illness. In addition, it was reported that patients experienced reactogenicity events in the 0-10 days following TIV (dose 1 and 2), however absolute numbers were not reported. Outcome of patients is unknown.
fatigue Narrative: 48 yo male with PMH gout, plantar fasscitis, HLP, sleep apnea reported having HA, muscle pain, joint pain, fatigue after his first covid19 vaccine on 3/1/2021. Symptoms self-resolved. This was reported on 3/22/2021 when he returned for his second dose.
FATHER STATES THAT SON HAD SWELLING IN BOTH LEGS FROM HIPS TO KNEES AND COULD NOT WALK.  HE ALSO STATES THAT SON HAD PAIN AND STIFFNESS IN LOWER BACK, AND A 100.1 TEMP APPROXIMATELY 3 HOURS AFTER RECEIVING HIS IMMUNIZATIONS ON 7/13/2005.  HE DID NOT CALL DR. (SON'S PEDIATRICIAN) UNTIL TODAY (7/14/2005) AFTER HE SPOKE TO ME AT THE CITY HEALTH DEPARTMENT. HE INFORMED ME THAT HE MASSAGED HIS SON (STATING THAT HE IS A MASSAGE THERAPIST) AND WAS ABLE TO GET THE SWELLING DOWN AND THE PAIN TO SUBSIDE.  I ASKED IF HE HAD GIVEN SON TYLENOL AS WE INSTRUCTED THE MOTHER TO DO (SHE BROUGHT SON IN FOR SHOTS), BUT FATHER STATED THAT HE WAS NOT TOLD BY MOTHER THAT HE NEEDED TO DO THAT .
got a first dose of the Moderna vaccine and then got a Pfizer vaccine as a second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (got a first dose of the Moderna vaccine and then got a Pfizer vaccine as a second dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (got a first dose of the Moderna vaccine and then got a Pfizer vaccine as a second dose). On 28-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (got a first dose of the Moderna vaccine and then got a Pfizer vaccine as a second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No Treatment medications were provided.
Headache, dizziness, diarrhea, nausea, vomiting, brain fog, tremors, weakness, exhaustion
On 04/27/2022, I had body aches, fever of 103, eyes burning, my taste was off, severely lethargic. COVID-19 Test was positive.  I isolated and rested.
Hives and swelling in face around eyes and forehead.  Hives were everywhere on the body
Vaccine x2 as above on 9Sept17, soreness to arm and shoulder began 10Sept17 mid-afternoon and progressively got worse through the evening. Woke up 11Sept w limited to no ROM of Left arm/shoulder. Job is construction work. Unable to function in his line of work and called in sick Mon and Tues (12Sept). On Mon took MOTRIN OTC and used ICY HOT topically with cool compresses to shoulder, without relief. C/O nausea on Mon and Tues as well w/o vomiting. Pain started to subside on Tues mid-afternoon and was able to return to work on 13Sept17. Today c/o pain at injection sites and tenderness to touch, but ROM has returned to normal. No medical tx sought for above conditions. NKDA/NKA, no meds and no significant PMH as identified above. Verified site locations with patient, states injection sites are at least 1 inch apart and approx. 2-3 finger widths from the bony prominence on shoulder. States this Anthrax shot felt different than previous Anthrax vaccines, c/o "numbing sensation" after insertion vs the normal stinging sensation he had remembered in the past. Technician told patient what med he was injecting each time prior to his vaccination (Anthrax vs Typhoid). Information on the Program provided to patient as he was inquiring about any compensation for lost work time d/t requirement. Encouraged to seek medical care if symptoms do not fully resolve.
Pt is 13 years old and received Peds Pfizer vaccine dose of 0.2ml, did not receive appropriate dose for age.
PPV administered 1st, then MCV4. 1 min after MCV4 admin, Pt developed mid sternal chest pain, difficulty breathing, nausea/vomiting, diaphoresis, and rash to chest, legs and arms. EMS activated. O2 provided via non-rebreather plus EPI pen administered.
MMR vaccine was given instead of Varicella vaccine. No adverse reaction has been reported to date.
blood titer were drawn and showed "non-reactive" for RECOMBIVAX; This spontaneous report was received from a physician referring to a 21-year-old male patient. The patient had no concomitant medications, pertinent medical history or drug reactions/allergies.     In 1999, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (1 dosage form; strength, route, lot # and expiration date were not reported) on the recommended schedule when he was a child for prophylaxis.         On 10-DEC-2020, his blood titer was drawn and showed "non-reactive" for hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (hepatitis b surface antibody negative). The patient saw the physician. The outcome of the event was unknown. The causality assessment was not reported.
Arm pain in injection site since vaccination; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Arm pain in injection site since vaccination) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced INJECTION SITE PAIN (Arm pain in injection site since vaccination). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Arm pain in injection site since vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medication included unspecified high blood pressure medications.
Very stiff and sore, entire bodyaches especially left shoulder and neck  beginning a few hours after Tuesday injection and  lasted thru day 3.  Very frequent urination. Shakiness, trembling, weak. Feet and hands extremely cold and would not warm up (started night of injection about 10 pm and lasted until approx 2 am). Whole body shivering so strong walking was difficult. minor dull headache thru Friday treated with Motrin. Sinus headache Friday in addion to tiring easily and frequent urination. Saturday Just feel very tired, weak and frequent urination. No headache today.
Patient complained of sore arm the evening after receiving the Pfizer Booster. Today she reported that this morning (1-20-22) she has swelling in her left arm pit.
Arm pain; arm swelling; arm redness; felt weird; "didn't feel like myself in my head"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (arm swelling), ERYTHEMA (arm redness), FEELING ABNORMAL (felt weird) and CONFUSIONAL STATE ("didn't feel like myself in my head") in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (arm swelling), ERYTHEMA (arm redness), FEELING ABNORMAL (felt weird) and CONFUSIONAL STATE ("didn't feel like myself in my head"). On 08-Mar-2021, PAIN IN EXTREMITY (Arm pain) had resolved. On 11-Mar-2021, FEELING ABNORMAL (felt weird) and CONFUSIONAL STATE ("didn't feel like myself in my head") had resolved. On 18-Mar-2021, PERIPHERAL SWELLING (arm swelling) and ERYTHEMA (arm redness) had resolved.            Concomitant product use was not provided by the reporter.   ? No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: TCR was received  Patient did not report AE from 2nd vaccine as she stated they all seem to be pretty normal to her. Patient declined to provide additional contact info for further follow up as everything has resolved and she doesn't feel the need
Information has been received from a nurse practitioner concerning a female patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently the patient got a rash in the torso area from the neck to the pelvis. The patient was very itchy with a really bad rash. The patient sought unspecified medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
1hr p/vax eyes swollen, tearing, itchy, that evening hives on legs, precipitated asthma attack;parent notified MD who recommended asthma tx & DPH
I started experiencing symptoms on 08/14/2022 and tested positive for COVID-19 on 8/16 and 8/17. I had a really high fever at 102.5 and just total lethargy. I didn't move out of the chair much unless I needed to go to the bathroom or drink some fluid. It hit me a lot harder than the first time as far as fevers. I had headaches, congestion, and some shortness of breath. From the first round of COVID-19, that's when I started with my heart and lung symptoms. So for this infection, I already knew what was going on with my symptoms. I was just unable to function at all. I talked to my doctor via telehealth and told her I wasn't feeling well. She said she would send a prescription of Paxlovid just in case. I didn't take it because I didn't want to add to some of the problems I already have. I just stuck to fluids. I felt really bad for a full week. Out of commission and it was really tough. Most of it was fever, body aches, and chills. The headache did not go away, and I thought it would with the infection. I tried Tylenol and other medications, but nothing would knock it down. I didn't go to the hospital or anything, but it was not a nice experience. All other symptoms subsided but the headache persisted 24/7. I talked to my doctor and mentioned that my headache would not go away and nothing helped. I was having trouble focusing and I couldn't keep track of the things I was doing because it was distracting. My doctor said to get a CT because of the aneurysm. She also wanted to check to see if there was anything else causing this headache. I walked in to get my first CT done and compared to my old CTs and they saw no changes with the aneurysm. There was no sinus infection, so it was bizarre. Many health care providers noted that sometimes people with an autoimmune factor, after getting the COVID-19 infection, may get horrible headaches because the body cannot handle the spike protein. My PCP put me on  Neurontin, which was 100mg one week, 200mg the next week, and 300mg the third week. It didn't help too much. I'm currently taking 900mg of  Neurontin a day and the pain is now actually under control. I take that 3 times a day. I've been on that for a while now. I don't know what could happen if I get off of the medication because I'm not sure if the headache will come back or not. I started taking the medication on October 5, 2022. My biggest fear is I don't want to be on this medication for the rest of my life. We don't know what's going on. All of my doctors have said the same thing with the protein. I'm going back to the doctor in January and they may attempt to lower my dosage and get me off it and see the results. The sense of smell from the infection is getting better. I had smelled some perfume and it smelled different. With cooking, there was some things that I didn't smell well either. I think the smelling symptoms are getting better.
FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced fever. Laboratory data (dates unspecified) included: Fever (NR: not provided) 102 (unit unspecified), 101 (unit unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
I missed my period for nearly 2 months after getting vaccination on Dec 18, 2019, including Dec 2019 and Jan 2020 and continues now.
Started with a sore and tingly arm.  Shortly after I had severe lower abdominal pain. Then a rash appeared on my face which multiple dermatologist could not figure out.  Eventually it went away.  Diagnosed with IBS in early 2008 after doctors could not figure out anything based on blood work, colonoscopy and endoscopy.  Muscles also became very weak.  Dislocated my shoulder on a simple fall shortly after vaccination.  When IBS seemed to go away I started getting migraines and then was diagnosed with chronic migraine syndrome in early 2011.  They were insanely bad!  Almost nothing helped to relieve the pain.  In the middle of this I discovered a weird spot in a crease behind my ear.  Ended up being Melanoma stage 2 skin caner (April 2012).  Also, broke out in a similar rash as before which the doctors could not help.  Migraines continued.  November 2012 is when I lost feeling in my feet.  Legs were in a ton of pain and I had no balance.  Needed a cane to move.  My hips and butt had horrible shooting pains.  Migraines got worse.  Arms and hands were tingly and throbbed.  I had a very difficult time breathing.  I started getting confused and couldn't remember anything.  Tore a disc in my back from weakness.  I couldn't move, the pain was horrible and I felt so weak and fatigued.  Sleeping 16 hours a day!  The neurologist who I'd been going to every 3 weeks since my migraines was beyond baffled that all my MRI's and blood work came back normal.  It appears I had MS without MS. Vaccination injury came up thru a family member who had a hyperbaric chamber.  I tried the chamber and felt cured.  No more cane, pain, or difficulty breathing.  This was 3 weeks ago.  I need to use the chamber every few days and follow a strict blood type diet to feel ok.
The patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness.   Assessment : Time of assessment 1210. Alert and oriented and flushed, feeling like she will pass out, dizzy. .   Actions taken:  Patient walked out to the triage area with EMS. Vitals taken:  1212: BP 101/64 P 70 O2 sat 100% 1221: sitting-BP 108/70 P 70 99% sat 1223: standing-BP 102/66 P 76 100%; still c/o dizziness. 1237: BP sitting 103/69, P 59 100% sat 1240: BP standing 102/670 P 69 99% sat Patient was offered a snack, she refused saying she will go get lunch afterwards. She says she's more lightheaded than dizzy, she ambulated without difficulty. Advised if symptoms worsen or do not improve to go to the ED, she verbalized understanding. Ambulatory out with family member.   Medications administered: No medication administered.   Disposition:Home after additional 20 minute observation.
Information has been received from a physician concerning a pt who was over 50 years old who was vaccinated with a first dose of Pneumococcal 23v polysaccharide vaccine. Subsequently the pt experienced local swelling at the injection site. No additional information was available. Additional information had been requested.